Search Results

CSL regards stakeholder engagement as a foundation of corporate responsibility, and have identified our key stakeholders as patient groups, employees, investors, regulators, suppliers, government, healthcare professionals, plasma donors, business partners and the academic and scientific community.

https://corporateresponsibility.csl.com/approach/stakeholder-engagement

CSL's approach to community contributions is guided by our Code of Responsible Business Practice and Global Community Contributions Policy.

https://corporateresponsibility.csl.com/community

At CSL, Corporate Responsibility is about conducting our business ethically and contributing to the economic, social and environmental well-being of our communities.

https://corporateresponsibility.csl.com/

Read about CSL's approach to stakeholder engagement and review a summary of our performance in key areas such as innovation, safety and quality, community, and environment.

https://corporateresponsibility.csl.com/approach

In Australia, CSL contributes to a range of public policy debates in which we have expertise including biopharmaceuticals, medical research, patient advocacy and more.

https://corporateresponsibility.csl.com/marketplace/public-policy/australian-initiatives

CSL has an active program of supplier selection and management. In many cases, the selection of suppliers is primarily driven by stringent quality, regulatory or reliability constraints.

https://corporateresponsibility.csl.com/safety/supplier-management

I encourage you to review our Code to understand how it impacts your role and the way in which you represent CSL in business and the broader community.

https://corporateresponsibility.csl.com/-/media/csl/documents/crbp-languages/csl_crbp2021_english_external.pdf

CSL is committed to the development, manufacture and supply of high quality, safe products that save lives and improve the health and wellbeing of patients with serious diseases.

https://corporateresponsibility.csl.com/safety/plasma-therapies-and-vaccines

We act lawfully, honestly and fairly when competing in the market, and strive to fulfil our responsibilities to shareholders while facilitating access to our therapies for patients.

https://corporateresponsibility.csl.com/marketplace/competition-and-pricing

employee We welcome your direct enquiries a significant nature that have occurred centres, laboratories and administration opinion survey and community and feedback regarding our between the end of the reporting offices operated by CSL Plasma.

https://corporateresponsibility.csl.com/-/media/csl/corporate-responsibility-reports/csl-limited-corporate-responsibility-report-2018.pdf